156 related articles for article (PubMed ID: 10850424)
1. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
Castells A; Gusella JF; Ramesh V; Rustgi AK
Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
[TBL] [Abstract][Full Text] [Related]
2. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
Koreth J; Bakkenist CJ; McGee JO
Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
[TBL] [Abstract][Full Text] [Related]
3. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
Castells A; Ino Y; Louis DN; Ramesh V; Gusella JF; Rustgi AK
Gastroenterology; 1999 Oct; 117(4):831-7. PubMed ID: 10500065
[TBL] [Abstract][Full Text] [Related]
4. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
5. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
Chen T; Sahin A; Aldaz CM
Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
7. [Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers].
Duriez C; Schmitz A; Fouchet P; Buecher B; Thuille B; Lerebours F; Léger R; Boman F; Fléjou JF; Monges G; Paraf F; Bedossa P; Sabourin JC; Salmon RJ; Laurent-Puig P; Thomas G; Olschwang S
Gastroenterol Clin Biol; 1997; 21(5):358-64. PubMed ID: 9208010
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
[TBL] [Abstract][Full Text] [Related]
10. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
11. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.
Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF
Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
13. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
Aldaz CM; Chen T; Sahin A; Cunningham J; Bondy M
Cancer Res; 1995 Sep; 55(18):3976-81. PubMed ID: 7664266
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
[TBL] [Abstract][Full Text] [Related]
15. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
Sekido Y; Ahmadian M; Wistuba II; Latif F; Bader S; Wei MH; Duh FM; Gazdar AF; Lerman MI; Minna JD
Oncogene; 1998 Jun; 16(24):3151-7. PubMed ID: 9671394
[TBL] [Abstract][Full Text] [Related]
16. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.
Kalikin LM; Frank TS; Svoboda-Newman SM; Wetzel JC; Cooney KA; Petty EM
Oncogene; 1997 Apr; 14(16):1991-4. PubMed ID: 9150366
[TBL] [Abstract][Full Text] [Related]
17. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
[TBL] [Abstract][Full Text] [Related]
18. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
Parrella P; Scintu M; Prencipe M; Poeta ML; Gallo AP; Rabitti C; Rinaldi M; Tommasi S; Paradiso A; Schittulli F; Valori VM; Toma S; Altomare V; Fazio VM
Cancer Lett; 2005 May; 222(1):75-81. PubMed ID: 15837543
[TBL] [Abstract][Full Text] [Related]
19. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
[TBL] [Abstract][Full Text] [Related]
20. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
